Avizakimab Antibody
Avizakimab (BOS161721) is a humanized monoclonal antibody designed to neutralize interleukin-21 (IL-21) activity. It is a research tool for investigating IL-21's role in autoimmune pathologies, particularly systemic lupus erythematosus (SLE), and is utilized in both in vitro cellular assays and in vivo preclinical studies.
Product Specifications
Product Name Alternative
BOS 161721, BOS161721
Target
Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
10.384 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.12 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog